Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
CN Stock MarketDetailed Quotes
Daan Gene Co.,Ltd. (002030)
- 5.77
- 0.000.00%
Market Closed Apr 28 15:00 CST
8.10BMarket Cap-9.04P/E (TTM)
5.83High5.73Low93.99KlotVolume5.77Open5.77Prev Close54.31MTurnover0.67%Turnover RatioLossP/E (Static)1.40BShares8.2052wk High1.15P/B8.10BFloat Cap5.6452wk Low6.35Limit Up1.40BShs Float29.99Historical High5.19Limit Down1.73%Range %-2.92Historical Low--Dividend TTM5.78Avg Price49.91KlotAsk--Div Yield TTM100Lot Size42.41KlotBid
Daan Gene Co.,Ltd. (002030) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.65%149.44M | -11.18%757.66M | -14.81%503.51M | -15.44%338.57M | -14.71%169.14M | -27.76%853.02M | -29.83%591.05M | -25.33%400.38M | -41.85%198.31M | -90.20%1.18B |
| Operating revenue | -11.65%149.44M | -11.18%757.66M | -14.81%503.51M | -15.44%338.57M | -14.71%169.14M | -27.76%853.02M | -29.83%591.05M | -25.33%400.38M | -41.85%198.31M | -90.20%1.18B |
| Other operating revenue | ---- | 41.45%13.12M | ---- | 1.23%3.93M | ---- | 15.86%9.27M | ---- | -15.22%3.88M | ---- | 31.71%8M |
| Interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Commission income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Premiums earned | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total operating cost | -13.86%205.16M | -0.30%1.05B | 3.57%720.64M | 7.57%488.71M | 14.53%238.18M | -6.65%1.06B | -15.46%695.78M | -18.03%454.31M | -37.30%207.95M | -78.17%1.13B |
| Operating cost | -11.30%103.46M | -3.86%512.17M | -4.43%339.02M | -3.67%226.71M | 33.18%116.64M | -8.92%532.74M | -6.82%354.75M | -6.80%235.35M | -41.96%87.58M | -82.12%584.93M |
| Operating tax surcharges | 75.14%1.68M | 18.69%11.32M | -18.11%3.45M | -9.22%2.53M | -21.73%957.38K | -2.53%9.53M | -8.43%4.21M | -2.32%2.79M | -3.29%1.22M | -83.22%9.78M |
| Operating expense | -0.87%44.96M | 7.35%223.44M | 49.07%157.73M | 70.16%107.19M | 78.43%45.35M | 20.43%208.14M | -22.00%105.81M | -38.52%63M | -52.19%25.42M | -81.60%172.83M |
| Administration expense | 1.69%32.1M | 7.32%157.82M | -6.73%104.17M | -1.47%67.05M | -40.91%31.56M | 6.32%147.05M | -20.59%111.68M | -30.45%68.06M | -13.31%53.41M | -58.18%138.31M |
| Financial expense | 73.62%-2.71M | 44.41%-36.17M | 38.07%-29.61M | 42.36%-19.47M | 36.06%-10.29M | 12.95%-65.07M | 22.05%-47.81M | 36.74%-33.78M | -37.61%-16.09M | 32.68%-74.75M |
| -Interest expense (Financial expense) | -11.17%1.08M | -57.04%4.19M | -52.06%2.75M | -52.88%2.1M | -43.42%1.22M | -2.96%9.74M | 12.44%5.74M | 58.68%4.46M | 81.03%2.16M | -27.95%10.04M |
| -Interest Income (Financial expense) | 22.03%-10.26M | 30.48%-48.23M | 29.83%-37.46M | 29.17%-26.03M | 28.71%-13.16M | 16.52%-69.37M | 13.57%-53.39M | 19.34%-36.75M | 10.48%-18.45M | 16.63%-83.1M |
| Research and development | -52.41%25.68M | -17.43%186.34M | -12.71%145.88M | -11.95%104.7M | -4.35%53.95M | -25.36%225.67M | -24.96%167.13M | -21.73%118.91M | -26.18%56.4M | -56.96%302.33M |
| Credit Impairment Loss | 179.99%17.76M | 71.84%-114.85M | 30.33%-172.3M | -59.00%-171.13M | 54.22%-22.2M | -165.36%-407.83M | -459.60%-247.3M | -15,660.82%-107.63M | -467.25%-48.5M | 43.80%-153.69M |
| Asset Impairment Loss | 65.32%-1.21M | -482.35%-436.99M | -6,627.21%-7.67M | -6,688.26%-5.83M | -6,515.58%-3.49M | 71.44%-75.04M | 99.53%-113.95K | 99.43%-85.86K | --54.41K | 61.47%-262.75M |
| Other net revenue | -126.86%-43.58M | 47.12%-456.1M | 111.20%51.74M | 84.26%-66.23M | 138.29%162.22M | -1,263.03%-862.57M | -212.09%-462.03M | -182.98%-420.81M | -1,129.79%-423.66M | 114.12%74.17M |
| Fair value change income | -130.07%-60.35M | 102.60%4.57M | 273.25%206.55M | 127.89%85.57M | 154.91%200.73M | -140.34%-175.75M | -129.56%-119.22M | -163.93%-306.86M | -1,650.73%-365.57M | 429.26%435.69M |
| Invest income | 72.57%-6.79M | 119.47%49.43M | 96.17%-4.99M | 115.95%4.78M | -12.02%-24.75M | -867.13%-253.84M | -38,743.89%-130.11M | -249.13%-29.96M | -68.59%-22.1M | -109.68%-26.25M |
| Net open hedge income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Including: Investment income associates | 58.55%-10.83M | 102.29%6.21M | 77.40%-32.79M | 54.91%-20.35M | -1.05%-26.14M | -488.56%-271.33M | -967.16%-145.1M | -754.21%-45.14M | -62.28%-25.86M | -135.64%-46.1M |
| Exchange income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Asset deal income | 235.93%16.5K | -39.80%5.48M | 22.05%2.54M | 141.08%476.58K | 100.80%4.91K | 399.27%9.1M | 1,974.52%2.08M | ---1.16M | ---617.06K | -165.42%-3.04M |
| Other revenue | -41.34%7M | -11.10%36.26M | -15.41%27.6M | -20.02%19.91M | -8.71%11.93M | -51.55%40.79M | -58.14%32.63M | 9.29%24.89M | -25.19%13.07M | 8.38%84.2M |
| Operating profit | -206.56%-99.29M | 29.44%-753.35M | 70.82%-165.4M | 54.42%-216.37M | 121.50%93.18M | -977.81%-1.07B | -231.34%-566.76M | -197.06%-474.74M | -957.64%-433.31M | -98.08%121.62M |
| Add:Non operating Income | -97.85%17.09K | 53.93%3.98M | 462.95%2.46M | 1,095.09%1.53M | 526.82%793.13K | 36.76%2.58M | -71.54%436.84K | -91.40%128.42K | 121.24%126.53K | 98.34%1.89M |
| Less:Non operating expense | 304.31%568.97K | 23.94%7.61M | 327.28%6.63M | 209.29%4.35M | -84.15%140.73K | -38.43%6.14M | -55.47%1.55M | -57.14%1.41M | 35.52%887.74K | -11.49%9.98M |
| Total profit | -206.41%-99.84M | 29.33%-756.99M | 70.14%-169.57M | 53.95%-219.18M | 121.62%93.83M | -1,043.46%-1.07B | -232.19%-567.88M | -197.68%-476.02M | -969.44%-434.07M | -98.20%113.54M |
| Less:Income tax cost | -103.87%-1.65M | 117.82%23.53M | 71.68%-18.8M | 62.92%-29.06M | 158.37%42.57M | -415.88%-132.05M | -179.51%-66.38M | -188.14%-78.37M | -700.36%-72.93M | -95.31%41.8M |
| Net profit | -291.55%-98.2M | 16.89%-780.52M | 69.94%-150.77M | 52.19%-190.12M | 114.19%51.26M | -1,409.20%-939.11M | -244.90%-501.5M | -199.81%-397.65M | -1,055.96%-361.14M | -98.68%71.73M |
| Net profit from continuing operation | -291.55%-98.2M | 16.89%-780.52M | 69.94%-150.77M | 52.19%-190.12M | 114.19%51.26M | -1,409.20%-939.11M | -244.90%-501.5M | -199.81%-397.65M | -1,055.96%-361.14M | -98.68%71.73M |
| Net income from discontinuing operating | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Less:Minority Profit | 97.51%-41.34K | -159.22%-36.14M | -861.01%-9.27M | -606.19%-7.96M | -177.29%-1.66M | 57.66%-13.94M | 118.77%1.22M | 136.06%1.57M | 76.71%2.15M | -316.39%-32.93M |
| Net profit of parent company owners | -285.46%-98.15M | 19.54%-744.38M | 71.85%-141.5M | 54.37%-182.16M | 114.57%52.92M | -983.98%-925.17M | -242.58%-502.72M | -199.12%-399.22M | -1,093.65%-363.29M | -98.07%104.66M |
| Earning per share | ||||||||||
| Basic earning per share | -275.00%-0.07 | 19.70%-0.53 | 72.22%-0.1 | 53.57%-0.13 | 115.38%0.04 | -1,042.86%-0.66 | -243.31%-0.36 | -196.55%-0.28 | -1,096.17%-0.26 | -98.18%0.07 |
| Diluted earning per share | -275.00%-0.07 | 19.70%-0.53 | 72.22%-0.1 | 53.57%-0.13 | 115.38%0.04 | -1,042.86%-0.66 | -243.31%-0.36 | -196.55%-0.28 | -1,096.17%-0.26 | -98.18%0.07 |
| Other composite income | -311.63%-158.23K | 143.73%1.45M | -514.74%-521.83K | -242.60%-691.78K | -117.43%-38.44K | -281.66%-3.31M | -70.28%125.82K | 20.99%485.11K | 159.67%220.52K | 69.48%-867.08K |
| Other composite income of parent company owners | -80.07%-40.34K | 144.95%1.57M | -364.73%-430.78K | -234.23%-597.42K | -110.02%-22.4K | -227.20%-3.49M | -34.51%162.73K | 131.14%445.07K | 186.52%223.61K | 68.13%-1.07M |
| Other composite income of minority owners | -635.04%-117.9K | -166.99%-122.32K | -146.69%-91.04K | -335.68%-94.36K | -419.75%-16.04K | -8.75%182.6K | -121.11%-36.91K | -80.79%40.04K | 97.22%-3.09K | -60.53%200.11K |
| Total composite income | -292.01%-98.35M | 17.33%-779.07M | 69.82%-151.3M | 51.95%-190.82M | 114.19%51.22M | -1,429.89%-942.42M | -244.69%-501.38M | -199.59%-397.16M | -1,064.81%-360.92M | -98.69%70.86M |
| Total composite income of parent company owners | -285.62%-98.2M | 20.01%-742.81M | 71.76%-141.94M | 54.17%-182.76M | 114.57%52.9M | -996.46%-928.66M | -242.43%-502.56M | -198.96%-398.77M | -1,100.10%-363.07M | -98.08%103.59M |
| Total composite income of minority owners | 90.51%-159.24K | -163.55%-36.27M | -892.49%-9.36M | -599.48%-8.06M | -178.14%-1.68M | 57.96%-13.76M | 118.70%1.18M | 138.83%1.61M | 94.20%2.15M | -308.14%-32.73M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm